Relationship between COVID-19 and ICU-Acquired Bloodstream Infections Related to Multidrug-Resistant Bacteria
Antibiotics · 25.06.2023 · 12 (7) · 1105
DOI: 10.3390/antibiotics12071105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 25.06.2023. Verfasst von Antoine Piantoni und 11 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Lille, Service de Médecine Intensive Réanimation, F-59000 Lille, France. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A bloodstream infection (BSI) is a severe ICU-acquired infection. A growing proportion is caused by multidrug-resistant bacteria (MDRB). COVID-19 was reported to be associated with a high rate of secondary infections. However, there is a lack of data on the relationship between COVID-19 and the incidence of MDRB ICU-acquired BSI. The aim of this study was to evaluate the relationship between COVID-19 and ICU-acquired BSI related to MDRB. This retrospective study was conducted in a single-center ICU during a one-year period. All adult patients admitted for more than 48 h were included. The cumulative incidence of ICU-acquired BSI related to MDRB was estimated using the Kalbfleisch and Prentice method. The association of COVID-19 status with the risk of ICU-acquired BSI related to MDRB was assessed using cause-specific Cox’s proportional hazard model. Among the 1320 patients included in the analysis, 497 (37.65%) had COVID-19. ICU-acquired BSI related to MDRB occurred in 50 patients (36 COVID patients (7%) and 14 non-COVID patients (1.6%)). Extended-spectrum beta-lactamase Enterobacteriacae (46%) and carbapenem-resistant Acinetobacter baumannii (30%) were the most commonly isolated MDRB. COVID-19 was significantly associated with a higher risk of MDRB ICU-acquired BSI (adjusted cHR 2.65 (1.25 to 5.59) for the whole study period). However, this relationship was only significant for the period starting at day 15 after ICU admission. ICU-acquired BSI related to MDRB was significantly associated with ICU mortality (HR (95%CI) 1.73 (1–3)), although COVID-19 had no significant impact on this association (p het 0.94). COVID-19 is significantly associated with an increased risk of ICU-acquired BSI related to MDRB, mainly during the period starting at day 15 after ICU admission.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CHU de Lille, Service de Médecine Intensive Réanimation, F-59000 Lille, France.
- CHU de Lille, Laboratoire de Bactériologie-Hygiène, Centre de Biologie Pathologie, F-59000 Lille, France.
- Inserm U1285, Université de Lille, CNRS, UMR 8576-UGSF, F-59000 Lille, France.
- CNRS, UMR 8576-UGSF, F-59000 Lille, France.
- Inserm, U1285, F-59000 Lille, France.
- Centre for Antimicrobial Optimisation, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London W12 0HS, UK.
ORCID-Profile: Saad Nseir
Zitieren
APA
Piantoni, A., Houard, M., Piga, G., Zebian, G., Ruffier des Aimes, S., Holik, B., Wallet, F., Rouzé, A., Kreitmann, L., Loiez, C., Labreuche, J., & Nseir, S. (2023). Relationship between COVID-19 and ICU-Acquired Bloodstream Infections Related to Multidrug-Resistant Bacteria. Antibiotics, 12(7), 1105. https://doi.org/10.3390/antibiotics12071105
Vancouver
Piantoni A, Houard M, Piga G, Zebian G, Ruffier des Aimes S, Holik B, et al. Relationship between COVID-19 and ICU-Acquired Bloodstream Infections Related to Multidrug-Resistant Bacteria. Antibiotics. 2023;12(7):1105. doi:10.3390/antibiotics12071105
BibTeX
@article{Piantoni2023,
author = {Piantoni, Antoine and Houard, Marion and Piga, Gaetan and Zebian, Ghadi and Ruffier des Aimes, Sarah and Holik, Bérénice and Wallet, Frédéric and Rouzé, Anahita and Kreitmann, Louis and Loiez, Caroline and Labreuche, Julien and Nseir, Saad},
title = {Relationship between COVID-19 and ICU-Acquired Bloodstream Infections Related to Multidrug-Resistant Bacteria},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {7},
pages = {1105},
doi = {10.3390/antibiotics12071105}
}
EUVIMED